+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Veterinary Vaccines Market: By Type Type of Disease - Forecast 2017-2022

  • ID: 3501341
  • Report
  • Region: Global
  • 69 pages
  • IndustryARC
1 of 3
Vaccination is the process of imitating naturally acquired immunity through insertion of immunological components of pathogens. The term Vaccine was coined by Edward Jenner while working on the treatment of small pox in humans. The parameters for successful animal vaccine are different depending upon the animal groups. Vaccines have played a crucial role in elimination of host of diseases in animals such as classical swine fever and parvovirosis. But there are issues surrounding the use of vaccines such as safety, government regulations and the prevalence of disease in specific environment. The use of Veterinary Vaccines has immense potential to propel towards high growth.

The Veterinary Vaccines market is segregated on the basis of type of vaccines; Veterinary Viral Vaccines, Veterinary Bacterial Vaccines, Veterinary Parasite Vaccines and Veterinary Vaccines for Infectious Diseases. These are further segmented based on the type of pathogen such as Viral Vaccines, DNA Vaccines, Gene-Deleted Vaccines, Protozoal Vaccines and Cancer Vaccines. The Veterinary Vaccines market is also differentiated on the type of diseases. The vaccines are formulated individually for different animal subsets such as Bovine Vaccines, Porcine Vaccines, Feline Vaccines, Canine Vaccines, Poultry Vaccines and Equine Vaccines. The vaccines can be used to eradicate the disease, like rinderpest virus. However, the triumph of an experimental vaccine lies in its successful commercialization. The commercialization aspect depends upon external factors such as global perspective for specific disease, commercial vitality and extensive research.

Major players in the Veterinary Vaccines market are profiled with company overview, financial overview, business strategies, product portfolios, recent developments and market shares of the key players.

Some prominent players profiled are:
Merck Animal Health
Ceva Animal Health
Boehringer Ingelheim.

The Veterinary Vaccines account for only 23% of the overall animal health products market, but the market for Veterinary Vaccines is growing significantly due to technological advances and new diseases coming to light. The regulatory scenario associated with pre-clinical trials in veterinary vaccines is less stringent as compared to human vaccines. This reduces the market launch time period and research & development process. However, there are strict rules in Europe and US over the use of veterinary vaccines. The European Union has restricted the use of coccidiostats as poultry vaccine. The use of antibiotics is under scrutiny for development of veterinary vaccines. In U.S. the vaccine for non-infectious diseases falls under the jurisdiction of FDA which makes the regulatory scenario tough. However, other animal vaccines are registered under USDA which is relatively easier route. The Veterinary International Committee for Harmonization provides guidelines for European Union, Japan and US. The objective of the committee is to create technical benchmark for registration of veterinary vaccines.

The report also contains detailed and in-depth analysis of the segmentation of the Veterinary Vaccines market with respect to geographic regions The regions contained in the report have been segmented into Americas, Europe, Asia-Pacific (APAC) and Rest of the World (RoW). These regions are further categorized into eminent countries from the perspective of Veterinary Vaccines market.
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
Note: Product cover images may vary from those shown
2 of 3
1. Veterinary Vaccines Market - Market Overview

2. Executive Summary

3. Veterinary Vaccines Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis

4. Veterinary Vaccines Market - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New Entrants
4.4.4. Threat of Substitution
4.4.5. Threat of Competition

5. Veterinary Vaccines Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Opportunities Analysis
5.3. Product / Market Life Cycle Analysis

6. Veterinary Vaccines Market – By Type
6.1. Veterinary Viral Vaccines
6.1.1. Live Viral Vaccines
6.1.2. Inactivated Viral Vaccines
6.1.3. DIVA Vaccines (Differentiating Infected from Vaccinated Animals)
6.1.4. Molecularly Defined Subunit Vaccines
6.1.5. Genetically Engineered Viral Vaccines
6.1.6. Live Viral Vector Vaccines
6.1.7. DNA Vaccines
6.2. Veterinary Bacterial Vaccines
6.2.1. Conventional Live Vaccines
6.2.2. Conventional Inactivated Vaccines
6.2.3. Gene-Deleted Vaccines
6.2.4. Subunit Vaccines
6.3. Veterinary Parasite Vaccines
6.3.1. Protozoal Vaccines
6.3.2. Subunit Protozoal Parasite Vaccines
6.3.3. Helminth and Ectoparasite Vaccines
6.4. Veterinary Vaccines for Infectious Diseases
6.4.1. Allergy Vaccines
6.4.2. Cancer Vaccines

7. Veterinary Vaccines Market – By Type of Disease
7.1. Bovine Vaccines
7.1.1. Bovine Viral Diarrhea
7.1.2. Brucellosis
7.1.3. Foot and mouth disease
7.1.4. Bovine Clostridial disease
7.1.5. Infectious Bovine Rhinotracheitis
7.2. Porcine Vaccines
7.2.1. Porcine Parvovirus
7.2.2. Porcine Reproductive Respiratory Syndrome
7.2.3. Porcine Circovirus II
7.2.4. Swine Influenza
7.2.5. Auzeszky’s Disease
7.2.6. Swine Pneumonia
7.3. Feline Vaccines
7.3.1. Feline Rabies
7.3.2. Feline Panleukopenia
7.3.3. Feline Leukemia
7.4. Canine Vaccines
7.4.1. Canine Rabies
7.4.2. Canine Distemper
7.4.3. Canine Parvovirus
7.5. Poultry Vaccines
7.5.1. Infectious Bronchitis
7.5.2. Gumboro disease
7.5.3. Avian Influenza
7.5.4. Coccidiosis
7.5.5. Mycoplasma
7.5.6. Newcastle disease
7.5.7. Marek’s disease
7.6. Equine Vaccines
7.6.1. Strangles
7.6.2. Equine Influenza
7.6.3. Equine Encephalomyelitis
7.6.4. Tetanus
7.6.5. Equine Rhinopneumonitis

8. Veterinary Vaccines Market - Geographic Analysis
8.1. Introduction.
8.2. Americas
8.2.1. USA
8.2.2. Canada
8.2.3. Brazil
8.3. Europe
8.3.1. UK
8.3.2. Germany
8.3.3. Spain
8.3.4. Italy
8.3.5. France
8.4. APAC
8.4.1. China
8.4.2. Thailand
8.4.3. India
8.4.4. Australia
8.5. ROW

9. Market Entropy
9.1. New Product Launches
9.2. M&As, Collaborations, JVs and Partnerships

10. Company Profiles (Overview, Financials, SWOT Analysis – Top 5 Companies, Developments, Product Portfolio)
10.1. Bayer Healthcare
10.2. Bioniche Animal Health
10.3. Biogenesis Bago SA
10.4. Elanco Animal Health
10.5. Embrex Inc.
10.6. Fort Dodge Animal Health
10.7. Heska Corporation
10.8. Imugene Limited
10.9. Lohmann Animal Health
10.10. Merck Animal Healthcare
10.11. Merial Inc.
10.12. Virbac Corporation
10.13. Zoetis
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"

11. Appendix
11.1. Abbreviations
11.2. Sources
11.3. Research Methodology
11.4. Bibliography
11.5. Compilation of Expert Insights
11.6. Disclaimer
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown
Order Online - visit: https://www.researchandmarkets.com/reports/3501341